Literature DB >> 22437853

Expression of a biologically active GFP-α(S1)-casein fusion protein in Lactococcus lactis.

Suguru Shigemori1, Shinichi Yonekura, Takashi Sato, Maya Nakanishi, Hajime Otani, Takeshi Shimosato.   

Abstract

In this study, we successfully developed a recombinant strain of Lactococcus lactis NZ9000 (NZ9000) that produced green fluorescent protein fused to α(S1)-casein (GFP-α(S1)Cas). A modified lactic acid bacterial vector (pNZ8148#2) was constructed by inserting genes for GFP and α(S1)-casein, a major cow's milk allergen, and the resulting vector, pNZ8148#2-GFP-α(S1)Cas, was applied to the expression of recombinant GFP-α(S1)Cas protein (rGFP-α(S1)Cas) in NZ9000. After inducing expression with nisin, the production of rGFP-α(S1)Cas was confirmed by confocal laser microscopic analysis, and the expression conditions were optimized based on fluorescent analysis and western blotting results. Moreover, the in vitro treatment of splenocytes isolated from α-casein (≥70 % α(S)-casein)-immunized mice with rGFP-α(S1)Cas resulted in increased IL-13 mRNA expression. The observed allergic activity is indicative of the Th2-cell mediated immune response and is similar to the effects induced by exposure to α-casein. Our results suggest that the expression of rGFP-α(S1)Cas in NZ9000 may facilitate in vivo applications of this system aimed at improving the specificity of immunological responses to specific milk allergen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22437853     DOI: 10.1007/s00284-012-0111-x

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  22 in total

1.  Improved vectors for nisin-controlled expression in gram-positive bacteria.

Authors:  E M Bryan; T Bae; M Kleerebezem; G M Dunny
Journal:  Plasmid       Date:  2000-09       Impact factor: 3.466

2.  CpG oligodeoxynucleotides induce strong up-regulation of interleukin 33 via Toll-like receptor 9.

Authors:  Takeshi Shimosato; Megumi Fujimoto; Masanori Tohno; Takashi Sato; Mariko Tateo; Hajime Otani; Haruki Kitazawa
Journal:  Biochem Biophys Res Commun       Date:  2010-02-21       Impact factor: 3.575

3.  Reduced allergenic potency of VR9-1, a mutant of the major shrimp allergen Pen a 1 (tropomyosin).

Authors:  Gerald Reese; Julia Viebranz; Susan M Leong-Kee; Matthew Plante; Iris Lauer; Stefanie Randow; Mar San-Miguel Moncin; Rosalia Ayuso; Samuel B Lehrer; Stefan Vieths
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

4.  A novel GFP-fused eukaryotic membrane protein expression system in lactococcus lactis and its application to overexpression of an Elongase.

Authors:  Yan Niu; Jian Kong; Yi Xu
Journal:  Curr Microbiol       Date:  2008-09-04       Impact factor: 2.188

5.  Cloning, expression, and mapping of allergenic determinants of alphaS1-casein, a major cow's milk allergen.

Authors:  Ulrike Schulmeister; Heidrun Hochwallner; Ines Swoboda; Margarete Focke-Tejkl; Beate Geller; Mats Nystrand; Annika Härlin; Josef Thalhamer; Sandra Scheiblhofer; Walter Keller; Bodo Niggemann; Santiago Quirce; Christoph Ebner; Adriano Mari; Gabrielle Pauli; Udo Herz; Rudolf Valenta; Susanne Spitzauer
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

6.  Characterization of T cell epitopes in alphas1-casein in cow's milk allergic, atopic and non-atopic children.

Authors:  B Ruiter; V Trégoat; L M'rabet; J Garssen; C A F M Bruijnzeel-Koomen; E F Knol; E Hoffen
Journal:  Clin Exp Allergy       Date:  2006-03       Impact factor: 5.018

7.  Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.

Authors:  Praveen Mannam; Kevin F Jones; Bruce L Geller
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

8.  Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing.

Authors:  M J Gasson
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

Review 9.  Lactic acid bacteria as live vaccines.

Authors:  A Mercenier; H Müller-Alouf; C Grangette
Journal:  Curr Issues Mol Biol       Date:  2000-01       Impact factor: 2.081

Review 10.  Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria.

Authors:  Jerry M Wells; Annick Mercenier
Journal:  Nat Rev Microbiol       Date:  2008-05       Impact factor: 60.633

View more
  6 in total

1.  Construction of genetically modified Lactococcus lactis that produces bioactive anti-interleukin-4 single-chain fragment variable.

Authors:  Fu Namai; Suguru Shigemori; Tasuku Ogita; Takashi Sato; Takeshi Shimosato
Journal:  Mol Biol Rep       Date:  2020-09-02       Impact factor: 2.316

2.  Determination of lentiviral titer by surface enhanced Raman scattering.

Authors:  Courtney J Morder; Brian T Scarpitti; Karin M Balss; Zachary D Schultz
Journal:  Anal Methods       Date:  2022-04-07       Impact factor: 2.896

3.  Generation of dipeptidyl peptidase-IV-inhibiting peptides from β-lactoglobulin secreted by Lactococcus lactis.

Authors:  Suguru Shigemori; Kazushi Oshiro; Pengfei Wang; Yoshinari Yamamoto; Yeqin Wang; Takashi Sato; Yutaka Uyeno; Takeshi Shimosato
Journal:  Biomed Res Int       Date:  2014-08-03       Impact factor: 3.411

4.  Class I/II hybrid inhibitory oligodeoxynucleotide exerts Th1 and Th2 double immunosuppression.

Authors:  Yusuke Ito; Suguru Shigemori; Takashi Sato; Tomoyuki Shimazu; Konomi Hatano; Hajime Otani; Haruki Kitazawa; Takeshi Shimosato
Journal:  FEBS Open Bio       Date:  2012-11-12       Impact factor: 2.693

5.  Recombinant Lactococcus lactis NZ9000 secretes a bioactive kisspeptin that inhibits proliferation and migration of human colon carcinoma HT-29 cells.

Authors:  Bo Zhang; Angdi Li; Fanglei Zuo; Rui Yu; Zhu Zeng; Huiqin Ma; Shangwu Chen
Journal:  Microb Cell Fact       Date:  2016-06-10       Impact factor: 5.328

6.  Synergistic oligodeoxynucleotide strongly promotes CpG-induced interleukin-6 production.

Authors:  Shireen Nigar; Yoshinari Yamamoto; Takuma Okajima; Suguru Shigemori; Takashi Sato; Tasuku Ogita; Takeshi Shimosato
Journal:  BMC Immunol       Date:  2017-10-04       Impact factor: 3.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.